PHARMACEUTICAL RAW MATERIALS AND EXCIPIENTS OPTIONS

“The present scenario has exposed some structural weaknesses from the EU’s medicines supply chain along with a substantial dependence on non-EU nations around the world for active pharmaceutical ingredients,” Kyriakides reported. She encouraged that supply chain problems be dealt with in an EU pharmaceutical system anticipated for being launc